TrialJournal of cancer research and clinical oncology2015

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy.

M Thalgott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.